First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Clinical Cancer Research

Topics

Chemistry

Biochemistry

Medicine

Internal Medicine

Gastroenterology

Show all topics

DOI

10.1158/1078-0432.ccr-16-2272